Quarterly report pursuant to Section 13 or 15(d)

Inventory

v3.19.1
Inventory
3 Months Ended
Feb. 28, 2019
Inventory Disclosure [Abstract]  
Inventory

Note 4 – Inventory

Inventory is comprised of public cord blood banking specimens, collection kits, finished goods, work-in-process and raw materials. Collection kits are used in the collection and processing of umbilical cord blood and cord tissue stem cells, finished goods include products purchased or assumed for resale and for the use in the Company’s processing and storage service. Inventory in the Public Cord Blood Bank includes finished goods that are specimens that are available for resale. The Company considers inventory in the Public Cord Blood Bank that has not completed all testing to determine viability to be work in process. The components of inventory at February 28, 2019 and November 30, 2018 are as follows:

 

     February 28, 2019      November 30, 2018  

Raw materials

   $ —        $ —    

Work-in-process

     140,333        188,085  

Work-in-process – Public Bank

     —          —    

Finished goods

     74,290        5,262  

Finished goods – Public Bank

     15,909,863        15,831,081  

Collection kits

     15,817        19,163  

Inventory reserve

     (7,718      (7,718
  

 

 

    

 

 

 

Total inventory

   $ 16,132,585      $ 16,035,873